13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
33 檔
31.6%
In Q4 2025, First Light Asset Management, LLC's U.S. equity holdings reached a combined market value of $1.6B, distributed across 33 disclosed stock positions.
In Q4 2025, First Light Asset Management, LLC adopted a defensive or profit-taking posture, trimming 13 positions and completely liquidating 14 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AXGN | Axogen Inc | Stock-Other | 13.10% | -4.16% | -9.86% | |
| 2 | NEO | Neogenomics Inc | Stock-Healthcare | 9.02% | +4.42% | +1.09% | |
| 3 | SIBN | Si-bone Inc | Stock-Other | 7.59% | +2.00% | +162.42% | |
| 4 | PVLA | Palvella Therapeutics Inc | Stock-Other | 5.67% | -3.79% | +30.95% | |
| 5 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 4.36% | -5.56% | EXIT | |
| 6 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 4.25% | -0.45% | +26.84% | |
| 7 | ATRC | Atricure Inc | Stock-Other | 3.56% | -0.90% | +32.02% | |
| 8 | VERA | Vera Therapeutics Inc | Stock-Other | 3.37% | -1.13% | EXIT | |
| 9 | IRON | Disc Medicine Inc | Stock-Other | 3.18% | — | +126.30% | |
| 10 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 3.10% | -0.67% | -0.01% | |
| 11 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 2.99% | -0.13% | +11.22% | |
| 12 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 2.98% | — | +479.18% | |
| 13 | TWST | Twist Bioscience CORP | Stock-Other | 2.77% | +0.81% | -4.53% | |
| 14 | SLP | Simulations Plus Inc | Stock-Other | 2.74% | +0.32% | +156.45% | |
| 15 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 2.42% | -0.10% | +63.92% | |
| 16 | WVE | Wave Life Sciences Ltd. | Stock-Other | 2.41% | -1.20% | EXIT | |
| 17 | ANAB | Anaptysbio Inc | Stock-Other | 2.40% | -0.42% | -34.73% | |
| 18 | HCAT | Health Catalyst Inc | Stock-Other | 2.36% | +0.08% | -3.91% | |
| 19 | GH | Guardant Health Inc | Stock-Healthcare | 2.30% | +1.71% | +5.27% | |
| 20 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 2.09% | -0.57% | -0.79% | |
| 21 | ✓ | Establishment Labs Holdings In | Stock-Other | 2.08% | -0.28% | -10.82% | |
| 22 | MASS | 908 Devices Inc | Stock-Other | 1.94% | -0.01% | +92.64% | |
| 23 | KRMD | Koru Medical Systems Inc | Stock-Other | 1.87% | -0.60% | -7.01% | |
| 24 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 1.83% | +0.84% | — | |
| 25 | APGE | Apogee Therapeutics Inc | Stock-Other | 1.64% | +3.15% | — | |
| 26 | NPCE | Neuropace Inc | Stock-Other | 1.59% | -0.14% | -0.78% | |
| 27 | MDXG | Mimedx Group Inc | Stock-Other | 1.57% | -1.01% | EXIT | |
| 28 | ORGO | Organogenesis Holdings Inc | Stock-Other | 1.53% | -0.74% | EXIT | |
| 29 | SEPN | Septerna Inc | Stock-Other | 1.32% | +0.38% | — | |
| 30 | ABVX | Abivax Sa-adr | Stock-Other | 0.91% | — | -7.59% | |
| 31 | BFLY | Butterfly Network Inc | Stock-Other | 0.82% | +0.39% | +149.30% | |
| 32 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.23% | — | — | |
| 33 | IWO | Ishares Russell 2000 Growth | ETF-Small Cap | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SIBN | Si-bone Inc | +4.9% | +162.42% | Add |
| 2 | AXGN | Axogen Inc | +3.3% | -9.86% | Trim |
| 3 | MDGL | Madrigal Pharmaceuticals Inc | +2.5% | +479.18% | Add |
| 4 | PVLA | Palvella Therapeutics Inc | +2.5% | +30.95% | Add |
| 5 | VERA | Vera Therapeutics Inc | +2% | +71.50% | Add |
| 6 | NEO | Neogenomics Inc | +1.8% | +1.09% | Add |
| 7 | IRON | Disc Medicine Inc | +1.7% | +126.30% | Add |
| 8 | SLP | Simulations Plus Inc | +1.7% | +156.45% | Add |
| 9 | EWTX | Edgewise Therapeutics Inc | +0.8% | +11.22% | Add |
| 10 | RYTM | Rhythm Pharmaceuticals Inc | +0.7% | +63.92% | Add |
| 11 | GH | Guardant Health Inc | +0.7% | +5.27% | Add |
| 12 | BFLY | Butterfly Network Inc | +0.6% | +149.30% | Add |
| 13 | ATRC | Atricure Inc | +0.6% | +32.02% | Add |
| 14 | CRNX | Crinetics Pharmaceuticals In | +0.6% | +26.84% | Add |
| 15 | ✓ | Establishment Labs Holdings In | +0.5% | -10.82% | Trim |
| 16 | NPCE | Neuropace Inc | +0.3% | -0.78% | Trim |
| 17 | KRMD | Koru Medical Systems Inc | +0.2% | -7.01% | Trim |
| 18 | ABVX | Abivax Sa-adr | +0.1% | -7.59% | Trim |
| 19 | MASS | 908 Devices Inc | -0.1% | +92.64% | Add |
| 20 | TWST | Twist Bioscience CORP | -0.4% | -4.53% | Trim |
| 21 | IRTC | Irhythm Holdings Inc | -0.4% | -0.79% | Trim |
| 22 | ANAB | Anaptysbio Inc | -0.5% | -34.73% | Trim |
| 23 | MDXG | Mimedx Group Inc | -0.8% | -16.80% | Trim |
| 24 | AMLX | Amylyx Pharmaceuticals Inc | -1.2% | -0.01% | Trim |
| 25 | HCAT | Health Catalyst Inc | -1.3% | -3.91% | Trim |
| 26 | ORGO | Organogenesis Holdings Inc | -1.5% | -48.48% | Trim |
| 27 | 260 | Centessa Pharmaceuticals-adr | -4% | -37.32% | Trim |
| 28 | PFMTUSD | Performant Financial CORP | — | EXIT | Sold out |
| 29 | LENZ | Lenz Therapeutics Inc | — | EXIT | Sold out |
| 30 | WVE | Wave Life Sciences Ltd. | — | NEW | New buy |
| 31 | CDTX | Cidara Therapeutics Inc | — | EXIT | Sold out |
| 32 | TNDM | Tandem Diabetes Care Inc | — | NEW | New buy |
| 33 | APGE | Apogee Therapeutics Inc | — | NEW | New buy |
| 34 | ✓ | Merus N V | — | EXIT | Sold out |
| 35 | SEPN | Septerna Inc | — | NEW | New buy |
| 36 | ADMA | Adma Biologics Inc | — | EXIT | Sold out |
| 37 | CAI | Caris Life Sciences Inc | — | EXIT | Sold out |
| 38 | RARE | Ultragenyx Pharmaceutical In | — | EXIT | Sold out |
| 39 | SENS1GBP | Senseonics Holdings Inc | — | EXIT | Sold out |
| 40 | RGEN | Repligen CORP | — | EXIT | Sold out |
| 41 | GPCR | Structure Therapeutics Inc | — | EXIT | Sold out |
| 42 | EVH | Evolent Health Inc - A | — | EXIT | Sold out |
| 43 | ALHC | Alignment Healthcare Inc | — | EXIT | Sold out |
| 44 | RDNT | Radnet Inc | — | EXIT | Sold out |
| 45 | TECX | Tectonic Therapeutic Inc | — | EXIT | Sold out |
| 46 | DYN | Dyne Therapeutics Inc | — | NEW | New buy |
| 47 | IWO | Ishares Russell 2000 Growth | — | NEW | New buy |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 33 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including AXGN, NEO, SIBN) accounted for 31.6% of total reported equity market value during Q4 2025.
Top New Position Initiated
WVE
市值: $31.5M
Top Position Liquidated / Trimmed
PFMTUSD
前期市值: $90.6M
During Q4 2025, First Light Asset Management, LLC's top holdings by market value included AXGN (13.1%)、NEO (9.0%)、SIBN (7.6%). The largest single position, AXGN, represented 13.1% of total portfolio value.
In Q4 2025, First Light Asset Management, LLC made 47 total portfolio adjustments, initiating 6 new buys, adding to 14 positions, trimming 13 holdings, and fully liquidating 14 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.